This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
9/30/2026
Dr Shabir Hasham
Chief Medical Officer
Good afternoon and welcome to the Senthera Pharmaceuticals Holdings AG half-year results investor presentation.
Operator
Conference Operator
Throughout this recording meeting, investors will be in listen-only mode. Questions can be submitted at any time by the Q&A tab situated in the right-hand corner of your screen. Just simply type in your question and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can review all questions submitted and publish responses where it's appropriate to do so. Before we begin I'd like to submit the following poll. I'd now like to hand over to the Thera Pharmaceuticals Holdings team. Good afternoon.
Catherine Isted
Chief Financial Officer
Good afternoon and welcome to the first half results for the six months ending the 30th of June 2026. Giving the presentation today will be our new CEO Orlando Oliveira, myself Catherine Isted and our Chief Medical Officer Dr Shabir Hasham. Can I please encourage you to type in questions into the Q&A box as we go along and we will answer these at the end of the presentation. As always, we have a disclaimer. Please feel free to read this at your leisure. I now hand over to Orlando to go through the highlights of the first half of the year.
You're reading a preview of the 0QN1.L Q2 2026 earnings call.
Free account.
Disclaimer